食管癌手术患者延长与标准血栓预防的随机对照研究
这项开放标签随机对照试验纳入79例食管切除术患者,比较延长1个月低分子肝素血栓预防与标准住院预防。术后1个月两组凝血酶原片段F1+2水平无差异(P=0.41),静脉血栓发生率标准组13%、干预组15%。术前F1+2水平可预测术后1个月内静脉血栓发生。
要点
- 延长1个月低分子肝素预防与标准住院预防相比,术后1个月F1+2水平无差异(P=0.41)。
- 静脉血栓发生率标准组13% vs 干预组15%,两组相似。
- 术前F1+2每升高50 pmol/L,静脉血栓栓塞的OR为1.64(95%CI 1.17-2.54)。
核心结论
- 食管切除术后延长血栓预防未发现获益。
- 术前F1+2水平被发现是术后血栓栓塞发生的预测因素。
研究设计与样本
- 开放标签随机对照试验,纳入接受食管切除术的患者。
- 因入组缓慢,研究在达到预期样本量100例前终止,实际纳入79例。
- 主要终点为术后1个月标准组与干预组凝血酶原片段1+2(F1+2)水平的差异。
- 次要终点为静脉血栓栓塞事件发生率和死亡率。
主要发现
- 术后1个月随访时,标准组与干预组F1+2水平无差异(P=0.41)。
- 静脉血栓发生率标准组13% vs 干预组15%,两组相似。
- 发生术后1个月内静脉血栓的患者术前F1+2水平显著高于未发生者(P=0.01)。
- F1+2每升高50 pmol/L,静脉血栓栓塞的OR为1.64(95%CI 1.17-2.54)。
- 术后1个月内无患者死亡。
局限性
- 研究因入组缓慢在达到预期样本量100例前终止,实际纳入79例。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Recent guidelines recommend prolonged thromboprophylaxis after esophagectomy due to cancer. However, to our knowledge, no previous studies have examined if prolonged prophylaxis is superior to standard in-hospital prophylaxis. OBJECTIVES: We aimed to perform the first clinical randomized study testing the efficacy of a prolonged 1-month thromboprophylaxis with low-molecular-weight heparin vs the standard treatment. METHODS: The study was an open-label, randomized, controlled trial including patients undergoing esophagectomy. The primary endpoint was the difference in prothrombin fragment 1 + 2 (F1 + 2) levels 1 month after surgery between the standard group and the intervention group. The secondary endpoints were the incidence of venous thromboembolic events and mortality. RESULTS: The study was terminated before reaching the expected sample size of 100 patients due to low accrual. We included 79 patients. At follow-up 1 month after surgery, F1 + 2 levels did not differ between the standard group and the intervention group (P = .41). Incidence of venous thrombosis was similar in the 2 groups, with 13% in the standard group and 15% in the intervention group. Preoperative F1 + 2 levels were significantly higher in patients who developed a venous thrombosis within 1 month after surgery than in those who did not (P = .01). The odds ratio of venous thromboembolism per 50 pmol/L increase in F1 + 2 was 1.64 (95% CI, 1.17-2.54). No patients died within 1 month after surgery. CONCLUSION: No benefit of prolonged thromboprophylaxis after esophagectomy was found. Preoperative F1 + 2 levels were found to be a predictor for the incidence of postoperative thromboembolism.
引用
- Gyldenholm T, Madsen N, Katballe N, et al. Prolonged vs standard thromboprophylaxis in patients with esophageal cancer undergoing surgery: a randomized controlled study. J Thromb Haemost. 2025. PMID: 39842514. doi:10.1016/j.jtha.2025.01.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。